Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Article in English | MEDLINE | ID: mdl-32418870

ABSTRACT

Thyroid disorders are common in pediatrics. Tests of thyroid function are widely available and frequently ordered in the pediatric healthcare setting. This is sometimes driven by common signs or symptoms of thyroid disease. All too often, it is driven by patients and their parents requesting thyroid tests for nonspecific symptoms, such as fatigue, obesity or family history of thyroid disease. The decision to order thyroid tests, as well as which test(s) of thyroid function to order, deserves careful thought rather than a reflexive "thyroid panel" for every patient. Thyroid stimulating hormone (TSH) is the single most appropriate test of thyroid function when screening a pediatric or adolescent for thyroid disorders. Adding more tests only increases the likelihood that a minor (and often insignificant) abnormality will be found. These incidental abnormalities can create anxiety for the parent and child, and usually results in additional testing, referral to a pediatric endocrinologist, and further expense. This review will aim to guide the pediatric primary care provider on the choice of appropriate screening test(s) for acquired thyroid dysfunction in children and adolescents, as well as the proper interpretation of the test(s). Emphasis will be placed on the "slightly" abnormal thyroid screening test. Specific thyroid tests to be reviewed include TSH, (free) T4, (free) T3, and thyroid antibodies. Finally, this review will aim to guide decisions on follow-up, additional testing, and reasons for referral to a pediatric endocrinologist. Congenital hypothyroidism, including abnormalities on state newborn screening, will not be discussed.


Subject(s)
Thyroid Diseases/diagnosis , Thyrotropin/blood , Thyroxine/blood , Triiodothyronine/blood , Adolescent , Child , Diagnosis, Differential , Female , Humans , Male , Pediatricians , Thyroid Diseases/blood , Thyroid Function Tests
2.
J Pediatr Endocrinol Metab ; 33(2): 179-184, 2020 Feb 25.
Article in English | MEDLINE | ID: mdl-31812947

ABSTRACT

Background Insulin pumps are a frequently used technology among youth with type 1 diabetes. Air bubbles within insulin pump tubing are common, preventing insulin delivery and increasing the risk of large glycemic excursions and diabetic ketoacidosis (DKA). We sought to determine the prevalence of air bubbles in insulin pump tubing and identify factors associated with clinically significant air bubbles. Methods Fifty-three subjects were recruited over 65 office visits. The insulin pump tubing was visualized, and any air bubbles were measured by length. The length of air bubbles was then converted to time without insulin at the lowest basal rate. Generalized linear model (GLM) was used to determine the associations between air bubble size and other variables. Results Of the 65 encounters, 45 had air bubbles in the tubing. Five (5/65 = 7.7%) encounters had a time without insulin of more than 60 min. Air bubble size was inversely correlated with time since infusion set change (p < 0.001), and directly correlated with age of the subject (p = 0.049). Conclusions Significantly more air bubbles were found in the tubing of insulin pumps soon after infusion set change and with older subjects, suggesting a relationship with the technique of filling the insulin cartridge and priming the tubing.


Subject(s)
Diabetes Mellitus, Type 1/drug therapy , Hyperglycemia/etiology , Hypoglycemic Agents/administration & dosage , Insulin Infusion Systems/adverse effects , Insulin/administration & dosage , Adolescent , Adult , Biomarkers/analysis , Blood Glucose/analysis , Child , Child, Preschool , Diabetes Mellitus, Type 1/pathology , Female , Follow-Up Studies , Glycated Hemoglobin/analysis , Humans , Hyperglycemia/diagnosis , Insulin Infusion Systems/standards , Male , Prognosis , Young Adult
3.
Int J Pediatr Otorhinolaryngol ; 74(11): 1270-2, 2010 Nov.
Article in English | MEDLINE | ID: mdl-20880597

ABSTRACT

OBJECTIVE: To review the effectiveness and safety of surgical intervention for obstructive sleep apnea in Prader-Willi syndrome. BACKGROUND: The muscle hypotonia and obesity associated with Prader-Willi syndrome (PWS) result in a high rate of obstructive sleep apnea (OSA). The use of growth hormone therapy in these patients has been associated with sudden death, raising concerns that such treatment may exacerbate obstructive sleep apnea. As a result, it has been suggested that children with PWS be evaluated for OSA and indications for adenotonsillectomy prior to instituting growth hormone therapy. The true effectiveness of surgical intervention in these cases, however, remains in doubt. METHODS: Retrospective review of patients with a diagnosis of PWS who underwent adenoidectomy or adenotonsillectomy from January 2001 to July 2009 at a regional, tertiary care children's hospital. Patients underwent pre-operative and post-operative polysomnography. Differences between pre-operative and post-operative body-mass index (BMI), apnea-hypopnea index (AHI), and median oxygen saturation and oxygen saturation nadir were analyzed. RESULTS: Five patients were identified during the study period. Three patients underwent adenotonsillectomy, 1 patient adenoidectomy alone, and another adenotonsillectomy with uvulopalatopharyngoplasty (UPPP). While median AHI was found to have decreased from 16.4 to 4.4, no statistically significant change could be demonstrated (p=0.274). Mean O(2) and nadir O(2) saturation also improved, but without reaching statistical significance. No intra-operative complications were noted. CONCLUSIONS: Our series, and other small case series, have demonstrated that complete resolution of sleep apnea in PWS patients is difficult to obtain with upper airway surgery alone. It is suggested that children with PWS being considered for growth hormone therapy undergo assessment for OSA by polysomnography. Patients identified with OSA should be referred for management by tonsillectomy and/or continuous positive airway pressure (CPAP) and then reassessed for residual airway obstruction prior to instituting hormonal therapy.


Subject(s)
Adenoidectomy , Growth Hormone/adverse effects , Prader-Willi Syndrome/complications , Sleep Apnea, Obstructive/surgery , Tonsillectomy , Adolescent , Child , Child, Preschool , Growth Hormone/administration & dosage , Humans , Infant , Obesity/complications , Oxygen/blood , Polysomnography , Retrospective Studies , Sleep Apnea, Obstructive/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...